FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $6,075,724 | -16.9% | 602,153 | +84.5% | 0.19% | -22.2% |
Q3 2022 | $7,315,000 | +12.2% | 326,419 | +24.0% | 0.24% | +7.2% |
Q2 2022 | $6,521,000 | -17.9% | 263,156 | +28.4% | 0.22% | +13.2% |
Q1 2022 | $7,946,000 | +1.8% | 204,945 | +53.6% | 0.20% | +22.4% |
Q4 2021 | $7,805,000 | +76.8% | 133,401 | +79.1% | 0.16% | +91.7% |
Q3 2021 | $4,415,000 | – | 74,492 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $197,709,000 | 22.51% |
Redmile Group, LLC | 12,957,222 | $758,127,000 | 17.24% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $60,690,000 | 6.28% |
Casdin Capital, LLC | 3,400,000 | $198,934,000 | 5.61% |
Ally Bridge Group (NY) LLC | 270,000 | $15,798,000 | 5.52% |
DAFNA Capital Management LLC | 372,160 | $21,775,000 | 5.48% |
Tri Locum Partners LP | 142,032 | $8,310,000 | 3.27% |
Kynam Capital Management, LP | 95,561 | $5,591,000 | 2.99% |
Artal Group S.A. | 1,800,000 | $105,318,000 | 2.86% |
Bellevue Group AG | 3,775,736 | $220,918,000 | 2.28% |